These findings are consistent with our results that MMP-9 levels in patients with RAAA were significantly higher than those in patients with URAAA and that MMP-9 concentration exceeding 461.08 ng/ml may indicate the risk of AAA rupture. Here, MMP9 is linked to triple-A syndrome.